Nchi: Uingereza
Lugha: Kiingereza
Chanzo: VMD (Veterinary Medicines Directorate)
Ampicillin
Cross Vetpharm Group Ltd
amended)
Ampicillin
Capsule, hard
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Antimicrobial
Authorized
2000-03-24
Revised: April 2010 (ATCVet code amended) SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ampicare, 250mg, hard capsule 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active Ingredient mg per capsule Ampicillin 250 (as ampicillin trihydrate) Capsule Body Erythrosine (E127) 0.952 Quinoline Yellow (E104) 0.004 Patent Blue V (E131) 0.002 Titanium Dioxide (E171) 0.368 Capsule cap Ferric Oxide black (E172) 0.146 Titanium Dioxide (E171) 0.488 Ink: Black Iron Oxide (E172) For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Capsule, hard. Red and grey coloured hard gelatine capsule with the logo, AMP 250, in black ink. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Indicated in the treatment and control of diseases caused by or associated with bacterial pathogens sensitive to ampicillin. These include the following groups of pathogens: _Streptococcus_ spp., _Pasturella haemolitica, P. multocida, Staphylococcus aureus _ and other pathogenic staphylococci. Page 1 of 5 Revised: April 2010 (ATCVet code amended) When susceptible organisms are present treatment may be effective in the following indications: alimentary tract infections respiratory infections urinary tract infections 4.3 CONTRAINDICATIONS Not to be administered to animals known to be sensitive to penicillin. Not to be administered to small herbivores. Do not treat dogs of less than 10 kg bodyweight. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES As with all penicillins, the product may cause hypersensitivity (allergy) following ingestion. It should not be used when the dog is known to be allergic to penicillins. As with all other penicillins, bacterial resistance to ampicillin may occur. Thus antibiotic sensitivity testing should be considered if a clinical condition fails to respond to treatment within 3 to 5 days. 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals For oral administration only. ii. Special precautions to be taken by the p Soma hati kamili